Table 8Summary description of all studies reporting on improvement

No. Studies (N)
Code*ABCC+HC+THH+N+TNN+TTUVP
A30351 (90)10 (6112)
B3091 (231)1 (358)1 (43)
C13202 (371)2 (124)2 (289)7 (1470)
C+H291 (58)
C+T186
H3661 (186)2 (466)
H+N+T1191 (80)
N9671 (42)3 (75)10 (1177)
N+T1982 (228)1 (93)
T107415 (1717)
U122
V661 (115)
P5584

Comparisons below the diagonal are omitted (blank cells). Blank cells above the diagonal indicate that no studies compared the interventions.

*

See Figure 11. Codes: A: alpha agonist, B: onabotulinum toxin A, C: anticholinergic, H: hormones, N: neuromodulation, T: behavioral therapy, U: periurethral bulking, V: intravesical pressure release, P: sham/no treatment/placebo.

Number of studies (and total sample size) comparing row and column intervention categories. Numbers across the diagonal (e.g., with A as both row and column header) are the total sample size for each intervention category. Blank cells above the diagonal imply that no studies directly compared the intervention categories.

From: Results

Cover of Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update
Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 212.
Balk E, Adam GP, Kimmel H, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.